Tech Company Financing Transactions
ThinkGenetic Funding Round
On 2/20/2019, ThinkGenetic raised $1.5 million in investment from private investors.
Transaction Overview
Company Name
Announced On
2/20/2019
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors
private investors (Lead Investor) (Cian Robinson)
Proceeds Purpose
ThinkGenetic plans to use the funds to expand its range of services and personnel, create new partnerships and develop new cutting-edge technology to complement current offerings.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
328 Old Lancaster Rd.
Sudbury, MA 01776
USA
Sudbury, MA 01776
USA
Phone
Website
Email Address
Overview
ThinkGenetic locates individuals with diagnosed and undiagnosed genetic diseases using artificial intelligence (AI) solutions. Co-founded by a patient advocate and a genetic counselor, we know firsthand that people can wait a long time to receive a genetic diagnosis. People also have the power within themselves to shorten this diagnostic odyssey.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Jacob
Founder
Dawn Laney
President
Len Barker
VP - Bus. Development
Peter Wilkerson
VP - Marketing
Ruth O'Keefe
Browse more venture capital transactions:
Prev: 2/20/2019: nsKnox venture capital transaction
Next: 2/20/2019: Orai venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs